Global Eye Disease Stem Cell Therapy Market Growth (Status and Outlook) 2024-2030

July 2024 | 104 pages | ID: GD36A747148AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Eye Disease Stem Cell Therapy market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Eye Disease Stem Cell Therapy Industry Forecast” looks at past sales and reviews total world Eye Disease Stem Cell Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Eye Disease Stem Cell Therapy sales for 2023 through 2029. With Eye Disease Stem Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eye Disease Stem Cell Therapy industry.

This Insight Report provides a comprehensive analysis of the global Eye Disease Stem Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Eye Disease Stem Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Eye Disease Stem Cell Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eye Disease Stem Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eye Disease Stem Cell Therapy.

United States market for Eye Disease Stem Cell Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Eye Disease Stem Cell Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Eye Disease Stem Cell Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Eye Disease Stem Cell Therapy players cover Lineage Cell Therapeutics, Astellas Pharma, Riken, Sumitomo Chemical, Senju Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Eye Disease Stem Cell Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Autologous
• Allogeneic

Segmentation by Application:

• Preclinical
• Clinical Phase 1,2

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Segmentation by Type:

• Autologous
• Allogeneic

Segmentation by Application:

• Preclinical
• Clinical Phase 1,2

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Lineage Cell Therapeutics
• Astellas Pharma
• Riken
• Sumitomo Chemical
• Senju Pharmaceutical
• Healios
• Centre National de la Recherche Scientifique
• Mayo Clinic
• Intellia Therapeutics
• Neurotech USA
• Ecole Normale Supйrieure de Paris
• Eyestem Research
• EyeCyte

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Eye Disease Stem Cell Therapy Market Size 2025-2030
  2.1.2 Eye Disease Stem Cell Therapy Market Size CAGR by Region
2.2 Eye Disease Stem Cell Therapy Segment by Type
  2.2.1 Autologous
  2.2.2 Allogeneic
2.3 Eye Disease Stem Cell Therapy Market Size by Type
  2.3.1 Global Eye Disease Stem Cell Therapy Market Size Market Share by Type (2025-2030)
  2.3.2 Global Eye Disease Stem Cell Therapy Market Size Growth Rate by Type (2025-2030)
2.4 Eye Disease Stem Cell Therapy Segment by Application
  2.4.1 Preclinical
  2.4.2 Clinical Phase 1,2
2.5 Eye Disease Stem Cell Therapy Market Size by Application (2025-2030)
  2.5.1 Global Eye Disease Stem Cell Therapy Market Size Market Share by Application (2025-2030)
  2.5.2 Global Eye Disease Stem Cell Therapy Market Size Growth Rate by Application (2025-2030)

3 EYE DISEASE STEM CELL THERAPY KEY PLAYERS

3.1 Date of Key Players Enter into Eye Disease Stem Cell Therapy
3.2 Key Players Eye Disease Stem Cell Therapy Product Offered
3.3 Key Players Eye Disease Stem Cell Therapy Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players Eye Disease Stem Cell Therapy Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 EYE DISEASE STEM CELL THERAPY BY REGIONS

4.1 Eye Disease Stem Cell Therapy Market Size by Regions (2025-2030)
4.2 United States Eye Disease Stem Cell Therapy Market Size Growth (2025-2030)
4.3 China Eye Disease Stem Cell Therapy Market Size Growth (2025-2030)
4.4 Europe Eye Disease Stem Cell Therapy Market Size Growth (2025-2030)
4.5 Rest of World Eye Disease Stem Cell Therapy Market Size Growth (2025-2030)

5 UNITED STATES

5.1 United States Eye Disease Stem Cell Therapy Market Size by Type (2025-2030)
5.2 United States Eye Disease Stem Cell Therapy Market Size by Application (2025-2030)

6 EUROPE

6.1 Europe Eye Disease Stem Cell Therapy Market Size by Type (2025-2030)
6.2 Europe Eye Disease Stem Cell Therapy Market Size by Application (2025-2030)

7 CHINA

7.1 China Eye Disease Stem Cell Therapy Market Size by Type (2025-2030)
7.2 China Eye Disease Stem Cell Therapy Market Size by Application (2025-2030)

8 REST OF WORLD

8.1 Rest of World Eye Disease Stem Cell Therapy Market Size by Type (2025-2030)
8.2 Rest of World Eye Disease Stem Cell Therapy Market Size by Application (2025-2030)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN EYE DISEASE STEM CELL THERAPY

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 Lineage Cell Therapeutics
  11.1.1 Lineage Cell Therapeutics Company Details
  11.1.2 Lineage Cell Therapeutics Eye Disease Stem Cell Therapy Product Offered
  11.1.3 Lineage Cell Therapeutics Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.1.4 Lineage Cell Therapeutics Main Business Overview
  11.1.5 Lineage Cell Therapeutics News
11.2 Astellas Pharma
  11.2.1 Astellas Pharma Company Details
  11.2.2 Astellas Pharma Eye Disease Stem Cell Therapy Product Offered
  11.2.3 Astellas Pharma Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.2.4 Astellas Pharma Main Business Overview
  11.2.5 Astellas Pharma News
11.3 Riken
  11.3.1 Riken Company Details
  11.3.2 Riken Eye Disease Stem Cell Therapy Product Offered
  11.3.3 Riken Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.3.4 Riken Main Business Overview
  11.3.5 Riken News
11.4 Sumitomo Chemical
  11.4.1 Sumitomo Chemical Company Details
  11.4.2 Sumitomo Chemical Eye Disease Stem Cell Therapy Product Offered
  11.4.3 Sumitomo Chemical Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.4.4 Sumitomo Chemical Main Business Overview
  11.4.5 Sumitomo Chemical News
11.5 Senju Pharmaceutical
  11.5.1 Senju Pharmaceutical Company Details
  11.5.2 Senju Pharmaceutical Eye Disease Stem Cell Therapy Product Offered
  11.5.3 Senju Pharmaceutical Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.5.4 Senju Pharmaceutical Main Business Overview
  11.5.5 Senju Pharmaceutical News
11.6 Healios
  11.6.1 Healios Company Details
  11.6.2 Healios Eye Disease Stem Cell Therapy Product Offered
  11.6.3 Healios Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.6.4 Healios Main Business Overview
  11.6.5 Healios News
11.7 Centre National de la Recherche Scientifique
  11.7.1 Centre National de la Recherche Scientifique Company Details
  11.7.2 Centre National de la Recherche Scientifique Eye Disease Stem Cell Therapy Product Offered
  11.7.3 Centre National de la Recherche Scientifique Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.7.4 Centre National de la Recherche Scientifique Main Business Overview
  11.7.5 Centre National de la Recherche Scientifique News
11.8 Mayo Clinic
  11.8.1 Mayo Clinic Company Details
  11.8.2 Mayo Clinic Eye Disease Stem Cell Therapy Product Offered
  11.8.3 Mayo Clinic Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.8.4 Mayo Clinic Main Business Overview
  11.8.5 Mayo Clinic News
11.9 Intellia Therapeutics
  11.9.1 Intellia Therapeutics Company Details
  11.9.2 Intellia Therapeutics Eye Disease Stem Cell Therapy Product Offered
  11.9.3 Intellia Therapeutics Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.9.4 Intellia Therapeutics Main Business Overview
  11.9.5 Intellia Therapeutics News
11.10 Neurotech USA
  11.10.1 Neurotech USA Company Details
  11.10.2 Neurotech USA Eye Disease Stem Cell Therapy Product Offered
  11.10.3 Neurotech USA Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
  11.10.4 Neurotech USA Main Business Overview
  11.10.5 Neurotech USA News
11.11 Ecole Normale Supйrieure de Paris
11.12 Eyestem Research
11.13 EyeCyte

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Eye Disease Stem Cell Therapy Market Size CAGR by Region (2025-2030) ($ millions)
Table 2. Major Players of Autologous
Table 3. Major Players of Allogeneic
Table 4. Global Market Size by Type (2025-2030) ($ millions)
Table 5. Global Eye Disease Stem Cell Therapy Market Size Market Share by Type (2025-2030)
Table 6. Global Eye Disease Stem Cell Therapy Market Size by Application (2025-2030) ($ millions)
Table 7. Global Eye Disease Stem Cell Therapy Market Size Market Share by Application (2025-2030)
Table 8. Date of Global Key Players Enter into Eye Disease Stem Cell Therapy Market
Table 9. Global Key Players Eye Disease Stem Cell Therapy Product Offered
Table 10. Key Players Eye Disease Stem Cell Therapy Funding/Investment (Million USD)
Table 11. Funding/Investment by Regions
Table 12. Funding/Investment by End-Industry
Table 13. Key Players Eye Disease Stem Cell Therapy Valuation & Market Capitalization (Million USD)
Table 14. Key Players Mergers & Acquisitions, Expansion Plans
Table 15. Eye Disease Stem Cell Therapy New Product/Technology Launches
Table 16. Eye Disease Stem Cell Therapy Industry Partnerships, Agreements, and Collaborations
Table 17. Eye Disease Stem Cell Therapy Industry Mergers and Acquisitions
Table 18. Global Eye Disease Stem Cell Therapy Market Size by Regions 2025-2030 ($ millions)
Table 19. Global Eye Disease Stem Cell Therapy Market Size Market Share by Regions 2025-2030
Table 20. United States Eye Disease Stem Cell Therapy Market Size by Type (2025-2030) ($ millions)
Table 21. United States Eye Disease Stem Cell Therapy Market Size Market Share by Type (2025-2030)
Table 22. United States Eye Disease Stem Cell Therapy Market Size by Application (2025-2030) ($ millions)
Table 23. United States Eye Disease Stem Cell Therapy Market Size Market Share by Application (2025-2030)
Table 24. Europe Eye Disease Stem Cell Therapy Market Size by Type (2025-2030) ($ millions)
Table 25. Europe Eye Disease Stem Cell Therapy Market Size Market Share by Type (2025-2030)
Table 26. Europe Eye Disease Stem Cell Therapy Market Size by Application (2025-2030) ($ millions)
Table 27. Europe Eye Disease Stem Cell Therapy Market Size Market Share by Application (2025-2030)
Table 28. China Eye Disease Stem Cell Therapy Market Size by Type (2025-2030) ($ millions)
Table 29. China Eye Disease Stem Cell Therapy Market Size Market Share by Type (2025-2030)
Table 30. China Eye Disease Stem Cell Therapy Market Size by Application (2025-2030) ($ millions)
Table 31. China Eye Disease Stem Cell Therapy Market Size Market Share by Application (2025-2030)
Table 32. Rest of World Eye Disease Stem Cell Therapy Market Size by Type (2025-2030) ($ millions)
Table 33. Rest of World Eye Disease Stem Cell Therapy Market Size Market Share by Type (2025-2030)
Table 34. Rest of World Eye Disease Stem Cell Therapy Market Size by Application (2025-2030) ($ millions)
Table 35. Rest of World Eye Disease Stem Cell Therapy Market Size Market Share by Application (2025-2030)
Table 36. Key Market Drivers & Growth Opportunities of Eye Disease Stem Cell Therapy
Table 37. Key Market Challenges & Risks of Eye Disease Stem Cell Therapy
Table 38. Key Industry Trends of Eye Disease Stem Cell Therapy
Table 39. Company A Company Details
Table 40. Companies Invested by Company A
Table 41. Company A Key Development and Market Layout
Table 42. Company B Company Details
Table 43. Companies Invested by Company B
Table 44. Company B Key Development and Market Layout
Table 45. Company C Company Details
Table 46. Companies Invested by Company C
Table 47. Company C Key Development and Market Layout
Table 48. Lineage Cell Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 49. Lineage Cell Therapeutics Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 50. Astellas Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 51. Astellas Pharma Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 52. Riken Basic Information, Head Office, Major Market Areas and Its Competitors
Table 53. Riken Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 54. Sumitomo Chemical Basic Information, Head Office, Major Market Areas and Its Competitors
Table 55. Sumitomo Chemical Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 56. Senju Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table 57. Senju Pharmaceutical Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 58. Healios Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. Healios Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 60. Centre National de la Recherche Scientifique Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. Centre National de la Recherche Scientifique Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 62. Mayo Clinic Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Mayo Clinic Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 64. Intellia Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Intellia Therapeutics Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)
Table 66. Neurotech USA Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. Neurotech USA Eye Disease Stem Cell Therapy Market Size (2023 VS 2028)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Eye Disease Stem Cell Therapy
Figure 2. Eye Disease Stem Cell Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Eye Disease Stem Cell Therapy Market Size Growth Rate 2025-2030 ($ millions)
Figure 7. Eye Disease Stem Cell Therapy Market Size by Region (2024 & 2030) ($ millions)
Figure 8. Global Eye Disease Stem Cell Therapy Market Size Market Share by Type (2025-2030)
Figure 9. Global Autologous Market Size Growth Rate
Figure 10. Global Allogeneic Market Size Growth Rate
Figure 11. Eye Disease Stem Cell Therapy in Preclinical
Figure 12. Global Eye Disease Stem Cell Therapy Market: Preclinical (2025-2030) ($ millions)
Figure 13. Eye Disease Stem Cell Therapy in Clinical Phase 1,2
Figure 14. Global Eye Disease Stem Cell Therapy Market: Clinical Phase 1,2 (2025-2030) ($ millions)
Figure 15. Global Eye Disease Stem Cell Therapy Market Size Market Share by Application (2025-2030)
Figure 16. Global Eye Disease Stem Cell Therapy Market Size in Preclinical Growth Rate
Figure 17. Global Eye Disease Stem Cell Therapy Market Size in Clinical Phase 1,2 Growth Rate
Figure 18. Funding/Investment
Figure 19. Global Eye Disease Stem Cell Therapy Market Size Market Share by Regions 2025-2030
Figure 20. United States Eye Disease Stem Cell Therapy Market Size 2025-2030 ($ millions)
Figure 21. China Eye Disease Stem Cell Therapy Market Size 2025-2030 ($ millions)
Figure 22. Europe Eye Disease Stem Cell Therapy Market Size 2025-2030 ($ millions)
Figure 23. Rest of World Eye Disease Stem Cell Therapy Market Size 2025-2030 ($ millions)
Figure 24. United States Eye Disease Stem Cell Therapy Consumption Market Share by Type in 2028
Figure 25. United States Eye Disease Stem Cell Therapy Market Size Market Share by Application in 2028
Figure 26. Europe Eye Disease Stem Cell Therapy Consumption Market Share by Type in 2028
Figure 27. Europe Eye Disease Stem Cell Therapy Market Size Market Share by Application in 2028
Figure 28. China Eye Disease Stem Cell Therapy Consumption Market Share by Type in 2028
Figure 29. China Eye Disease Stem Cell Therapy Market Size Market Share by Application in 2028
Figure 30. Rest of World Eye Disease Stem Cell Therapy Consumption Market Share by Type in 2028
Figure 31. Rest of World Eye Disease Stem Cell Therapy Market Size Market Share by Application in 2028